Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

583 results about "Staphylococcus aureus" patented technology

Staphylococcus aureus is a Gram-positive, round-shaped bacterium that is a member of the Firmicutes, and it is a usual member of the microbiota of the body, frequently found in the upper respiratory tract and on the skin. It is often positive for catalase and nitrate reduction and is a facultative anaerobe that can grow without the need for oxygen. Although S. aureus usually acts as a commensal of the human microbiota it can also become an opportunistic pathogen, being a common cause of skin infections including abscesses, respiratory infections such as sinusitis, and food poisoning. Pathogenic strains often promote infections by producing virulence factors such as potent protein toxins, and the expression of a cell-surface protein that binds and inactivates antibodies. The emergence of antibiotic-resistant strains of S. aureus such as methicillin-resistant S. aureus (MRSA) is a worldwide problem in clinical medicine. Despite much research and development, no vaccine for S. aureus has been approved.

Antibacterial peptide and antibacterial application thereof

The invention discloses an antibacterial peptide and antibacterial application thereof. The amino acid sequence of the antibacterial peptide is as shown in SEQ ID No.1, and the C end of the antibacterial peptide is amidated. The antibacterial peptide provided by the invention has the activity of resisting staphylococcus aureus and escherichia coli, and plays a role in inhibiting bacteria by destroying cell membranes. The antibacterial peptide is excellent in antibacterial activity, good in stability and not prone to generating drug resistance, can be used for synthesizing and preparing antibacterial compositions, and has great potential in application in the fields of food and medicine.
Owner:JINHUA INSTITUTE OF ZHEJIANG UNIVERSITY

Bacillus velezensis as well as fermentation product filtrate and biological product thereof

The invention discloses bacillus velezensis as well as fermentation product filtrate and a biological product thereof, and belongs to the technical field of microorganisms, a bacillus velezensis BTN-HB-F4 strain is separated and purified from prinsepia utilis royle in Harba snow mountain in Yunnan province, the fermentation product filtrate of the bacillus velezensis has excellent HAS inhibition capacity and remarkable DPPH and ABTS free radical scavenging capacity, and the biological product of the bacillus velezensis has the advantages that the biological product can be used for preparing biological products of the prinsepia utilis royle; a good anti-oxidation effect can be realized; secondly, under various concentrations, fermentation product filtrate can remarkably reduce the proportion of SA-beta-Gal positive cells, gene expression of matrix metalloproteinase 3 can be remarkably inhibited, and a good anti-aging effect is achieved; in addition, fermentation product filtrate can remarkably inhibit generation of zebra fish melanin and has a good whitening effect; the secretion amount of cell inflammatory factors IL-6 and TNF-alpha can be remarkably inhibited, and a good relieving effect is achieved; finally, the fermentation product filtrate can effectively inhibit the growth of pathogenic bacteria staphylococcus aureus, and has the potential of regulating the skin micro-ecology.
Owner:YUNNAN YUNKE CHARACTERISTIC PLANT EXTRACTION LABORATORY CO LTD +1

Lactobacillus plantarum YM-4-3 and application thereof

The invention discloses a lactobacillus plantarum YM-4-3 which is preserved in the China Center for Type Culture Collection on March 6, 2023, and the preservation number of the lactobacillus plantarum YM-4-3 is CCTCC (China Center for Type Culture Collection) NO: M2023253. The lactobacillus plantarum YM-4-3 disclosed by the invention has the advantages that the lactobacillus plantarum YM-4-3 can effectively improve constipation, has excellent DPPH free radical scavenging rate and ABTS free radical scavenging rate, has good acid resistance, cholate resistance and gastrointestinal tract adhesion capacity, has a very high survival rate in a gastrointestinal tract environment, can remarkably inhibit reproduction of gastrointestinal tract pathogenic bacteria, and can be used for treating constipation. Particularly staphylococcus aureus and salmonella typhimurium salmonella, and can be used for preparing products for preventing or improving constipation and antioxidant products.
Owner:朗恒科技集团有限公司

Extract based on roselle oil and roselle polypeptide as well as extraction method and application of extract

The invention relates to the related technical field of extraction of active ingredients in roselle calyx, and particularly provides an extract based on roselle oil and roselle polypeptide as well as an extraction method and application of the extract. The extraction method comprises the following steps: S1, sequentially performing crushing treatment and supercritical fluid extraction treatment on roselle calyx to obtain a roselle oil extract and flower residues; s2, the roselle residues are sequentially subjected to fermentation treatment and enzymolysis treatment, and a roselle polypeptide extract is obtained; wherein a strain used in the fermentation treatment is selected from at least one of saccharomyces cerevisiae, bacillus subtilis and lipomyces starkeyi; an enzyme used in the enzymolysis treatment is selected from at least one of acid protease and compound protease; the extract comprises the roselle oil extract and the roselle polypeptide extract. The extraction method provided by the invention improves the extraction rate of active ingredients extracted from roselle calyx.
Owner:BEIJING TECH & BUSINESS UNIV

Antibacterial peptide cAMP048 and application thereof

The invention provides an antibacterial peptide cAMP048 sourced from microorganisms in a deep sea environment and application of the antibacterial peptide cAMP048, and belongs to the technical field of peptide inhibitors. The antibacterial peptide cAMP048 has an amino acid sequence as shown in SEQ ID NO: 1 (Sequence Identity Number 1). The antibacterial peptide can inhibit the growth of acinetobacter baumannii at 64 mu M, inhibit the growth of multi-drug-resistant acinetobacter baumannii and multi-drug-resistant enterococcus faecium at 128 mu M and inhibit the growth of escherichia coli, staphylococcus aureus and multi-drug-resistant klebsiella pneumoniae at 256 mu M. The antibacterial peptide can be used for preparing products with antibacterial and / or bactericidal performance, and can be applied to preparation of antibacterial and / or bactericidal products. Such as food, skin care products or medical supplies.
Owner:BGI RESEARCH SANYA

Inflammation-targeting bionic extracellular vesicle as well as preparation method and application thereof

The invention discloses an inflammation-targeting bionic extracellular vesicle as well as a preparation method and application thereof, and particularly relates to the field of medicines. According to the invention, a new generation of aminoglycoside antibiotic teicoplanin (Teic), which is high in albumin binding rate and weak in intracellular antibacterial effect, is loaded on neutrophil-derived extracellular vesicles (NEV) with natural drug carrying capacity and inflammatory response chemotactic capacity to prepare the drug-loaded vesicles (Teic-NEV), wherein the new generation of aminoglycoside antibiotic teicoplanin (Teic) is used for loading the neutrophil-derived extracellular vesicles (NEV). The drug-loaded extracellular vesicle Teic-NEV can be used for targeted therapy of cells and tissues infected by MRSA (Methicillin-Resistant Staphylococcus Aureus). In vitro, the Teic (at) NEV can be used for destroying MRSA mature biological membranes and killing intracellular MRSA. According to the invention, the in-vivo and in-vitro biological safety of the TeicatNEV is evaluated. Therefore, the invention provides a certain theoretical basis for the application of NEV-based drug delivery in the field of intracellular bacteria treatment, and also provides a new treatment strategy for in-vivo targeted treatment.
Owner:ZHEJIANG UNIV

Nutritional composition, food containing same and application of nutritional composition

The invention relates to a nutritional composition. The nutritional composition comprises medium-chain and long-chain fatty acid triglyceride and nervonic acid in a mass ratio of (3: 1)-(1500: 1), and has a synergistic effect in the aspects of preventing or relieving diarrhea, inhibiting staphylococcus aureus in vivo or in vitro and / or preventing or treating inflammation. The invention also relates to a food product comprising said nutritional composition. The invention also relates to application of the nutritional composition in preparation of products with one or more purposes selected from 1) to 3): 1) preventing or relieving diarrhea; 2) inhibiting staphylococcus aureus in vivo or in vitro; and 3) preventing or treating inflammation.
Owner:INNER MONGOLIA MENGNIU DAIRY IND (GROUP) CO LTD +1

Soil staphylococcus H3 and application thereof

The invention discloses a Staphylococcus edaphicus H3, the preservation number of the Staphylococcus edaphicus H3 in Guangdong Microbial Culture Collection Center is GDMCC No: 64958, the strain H3 is applied to fermentation of meat products without nitrite, the Staphylococcus edaphicus H3 can promote color development of the meat products, and the Staphylococcus edaphicus H3 has relatively strong oxidation resistance, can effectively inhibit lipid peroxidation, and can be used for preparing the meat products. The staphylococcus aureus H3 can produce polysaccharide, the polysaccharide also plays an anti-oxidation role in a meat product processing process and is beneficial to maintenance of meat color, the strain H3 is inoculated to ferment sausages, the nitrite content in the sausages is obviously reduced, the hardness, cohesiveness, elasticity and chewiness of the sausages are improved, the taste of the sausages is richer, the delicate flavor is increased, and the sausages are more delicious. The strain H3 has no blood coagulation and hemolysis effects, is safe and reliable as a food additive, and is suitable for industrial production and market popularization and application.
Owner:AGRO PROD PROCESSING RES INST YAAS

Porcine bacillus velezensis YB-X-733 and application thereof

The invention discloses swine bacillus velezensis YB-X-733 and application thereof, and relates to the technical field of microorganisms. The swine-derived bacillus velezensis YB-X-733 is preserved in the China General Microbiological Culture Collection Center on September 24, 2024, the preservation number is CGMCC No.32057, the preservation address is No.3, Yard 1, Beichen West Road, Chaoyang District, Beijing, and the swine-derived bacillus velezensis YB-X-733 is classified and named as bacillus velezensis. The swine bacillus velezensis YB-X-733 disclosed by the invention has a good inhibition effect on escherichia coli, staphylococcus aureus and salmonella, and can be used for preparing a piglet inflammation resisting product. The swine-origin bacillus velezensis YB-X-733 disclosed by the invention can be used for obviously improving the metabolic capability of weaned piglets and improving the physiological status of the piglets; the immunocompetence of weaned piglets is improved, and inflammation is reduced; the microbial flora in the intestinal tracts of the weaned piglets can be obviously improved, the growth of harmful bacteria is inhibited, and the growth of beneficial bacteria is promoted.
Owner:SOUTHWEST UNIV OF SCI & TECH SICHUAN TIANFU NEW AREA INNOVATION RES INST +2

Nutritional composition and application thereof

The invention provides a nutritional composition and application of the nutritional composition. The nutritional composition comprises medium-chain and long-chain fatty acid triglyceride (MLCT) and milk fat globule membrane (MFGM) in a mass ratio of 2: 1 to 80: 1, and the combination of the two has the effects of synergistically improving diarrhea, inhibiting staphylococcus aureus in vivo or in vitro and / or regulating intestinal flora.
Owner:INNER MONGOLIA MENGNIU DAIRY IND (GROUP) CO LTD +1

Composition for detecting blood flow infection related pathogens

The invention belongs to the field of molecular biological detection, and provides a joint detection composition which is mainly used for detecting related pathogens by using a multiple fluorescent PCR (Polymerase Chain Reaction) analysis method. Therefore, at least four of staphylococcus aureus, staphylococcus capitis, bacteroides fragilis, streptococcus agalactiae, streptococcus salivarius and staphylococcus hominis are detected and distinguished in a single-tube reaction system at the same time. Meanwhile, the detection sensitivity of the composition is higher and reaches 200 copies / mL, and the detection is more accurate.
Owner:SANSURE BIOTECH INC

Pleuromutilin derivatives containing cycloalkyl group and preparation methods and applications thereof

Provided herein is a pleuromutilin derivative containing a cycloalkyl group and preparation method and application thereof. Specifically, the pleuromutilin is reacted with p-toluenesulfonyl chloride to obtain an intermediate I, and the intermediate I is reacted with 1-amino-2-methylpropane-2-thiol hydrochloride to obtain an intermediate II, and then the intermediate II is reacted with cycloalkylcarbonyl chloride to obtain a target derivative. The synthesis process of these derivatives is simple, with a high yield and simple purification. These derivatives can effectively inhibit activities of Staphylococcus aureus and Streptococcus, and have superior activities to the marketed Tiamulin, and they also have good antibacterial activities against drug-resistant bacteria. In particular, the treatment effect of the derivative 2 of the target derivative is significantly superior to the clinical drugs Tiamulin and Valnemulin. They are suitable as new antibacterial drugs for prevention and treatment of infectious diseases caused by bacteria in humans or animals.
Owner:LANZHOU INST OF ANIMAL SCI & VETERINARY PHARMA OF CAAS

Antibacterial coating with TaCu nano multilayer structure and preparation method thereof

The invention belongs to the technical field of biological coatings, and provides an antibacterial coating with a TaCu nano multilayer structure and a preparation method of the antibacterial coating. The antibacterial coating comprises a Cu layer and a Ta layer which are sequentially and alternately stacked on a base body, the Cu layer is in contact with the base body, and the Ta layer is the outermost layer. The Cu layers and the Ta layers are sequentially and alternately stacked on the substrate, the Cu < 2 + > layer-by-layer release delays the release rate, the cytotoxicity is reduced, and a lasting antibacterial effect is obtained; meanwhile, due to introduction of Ta, the osteogenesis performance of the matrix is effectively enhanced, and proliferation of bone cells is promoted. The antibacterial coating does not show cytotoxicity to rat bone marrow mesenchymal stem cells, can inhibit growth of staphylococcus aureus for a long time, is beneficial to promoting proliferation of osteoblasts, and can be used as an antibacterial coating for the surface of a bone implant. The preparation method of the antibacterial coating provided by the invention has the advantages of simple process, high deposition speed and high bonding strength.
Owner:SHANGHAI RUICHANG MEDICAL TECHNOLOGY CO LTD

Antibacterial peptide based on D-type amino acid and application thereof

The invention discloses an antibacterial peptide based on D-type amino acid and application of the antibacterial peptide, and the antibacterial peptide is characterized in that the amino acid sequence is w-r-r-w-r-r-w-w-r-k-r (dTrp-dArg-dArg-dTrp-dArg-dArg-dTrp-dTrp-dArg-dLys-dArg). The antibacterial peptide can be synthesized through an Fmoc solid-phase chemical method, the synthesis difficulty is low, and the in-vivo antibacterial activity is good. The antibacterial peptide especially has broad-spectrum killing activity on carbapenem-resistant pseudomonas aeruginosa, pseudomonas aeruginosa, klebsiella pneumoniae, escherichia coli, methicillin-resistant staphylococcus aureus and staphylococcus aureus, is low in hemolytic toxicity, can reach half or more of cell survival rate under medium and low concentration, almost has no toxic effect on cells, and can be used for preparing the antibacterial peptide with a broad-spectrum killing activity on carbapenem-resistant pseudomonas aeruginosa, klebsiella pneumoniae, escherichia coli, methicillin-resistant staphylococcus aureus and staphylococcus aureus. The stability is good, the operability is high, and the cost is low.
Owner:CHONGQING UNIV OF TECH

Preparation and application of anti-staphylococcus aureus IsdB antibody

The invention discloses preparation and application of an anti-staphylococcus aureus IsdB antibody. The antibody comprises a heavy chain variable region and a light chain variable region, the heavy chain variable region comprises HCDR1, HCDR2 and HCDR3 in the heavy chain variable region as shown in SEQ ID NO: 8; the light chain variable region comprises LCDR1, LCDR2 and LCDR3 in the light chain variable region as shown in SEQ ID NO: 16. The invention also provides nucleic acid for coding the antibody, a vector containing the nucleic acid and a cell containing the vector. In addition, experiments prove that the antibody can inhibit systemic infection of MRSA and resist invasion of MRSA to pneumonia, and has a good clinical application prospect.
Owner:CHONGQING YUANLUN BIOTECH

Double-probe detection reagent for detecting methicillin-resistant staphylococcus aureus and preparation method of double-probe detection reagent

The invention relates to a double-probe detection reagent for detecting methicillin-resistant staphylococcus aureus and a preparation method, and belongs to the technical field of food safety. The double-probe detection reagent is composed of a magnetic separation probe reagent solution and a fluorescent nano-enzyme probe reagent solution; the magnetic separation probe reagent liquid is used for specifically binding methicillin-resistant staphylococcus aureus and carrying out separation and enrichment treatment on a detection sample; the blue fluorescent nano-enzyme probe reagent solution is used for specifically combining, separating and enriching the methicillin-resistant staphylococcus aureus and generating a concentration dependent colorimetric signal and a fluorescent signal of the methicillin-resistant staphylococcus aureus. The magnetic separation probe has high specific surface area and super-strong magnetism, the capture efficiency is enhanced, and the magnetic attraction time is shortened; according to the invention, mutual verification is carried out between dual-mode signals, an internal proofreading effect is achieved, and the accuracy of a detection result is improved; the detection time of the method is within 1 h, the detection time is short, the detection sensitivity is high, and the method has good specificity for common type strains.
Owner:HEFEI UNIV OF TECH

Demethylhalaman-enoxacin conjugate as well as preparation method and application thereof

The invention relates to a norhalal-enoxacin conjugate as well as a preparation method and application thereof. The norhalal-enoxacin conjugate comprises a norhalal-enoxacin coupling compound, or a stereoisomer, a prodrug, a crystal form, a pharmaceutically acceptable salt, a pharmaceutically acceptable ester or a pharmaceutically acceptable solvate selected from the compound. Compared with enoxacin, kanamycin, streptomycin, lincomycin and azithromycin, the norharmann-enoxacin conjugate disclosed by the invention has a smaller MIC (Minimum Inhibitory Concentration) value, which shows that the norharmann-enoxacin conjugate has a better anti-staphylococcus aureus effect.
Owner:ZHEJIANG UNIV OF TECH

Ultra-short sequence antibacterial peptide rich in lysine and tryptophan, antibacterial peptide hydrogel and application thereof

The invention discloses an ultrashort-sequence antibacterial peptide rich in lysine and tryptophan, an antibacterial peptide hydrogel and application of the ultrashort-sequence antibacterial peptide and the antibacterial peptide hydrogel. The preparation method comprises the following steps: combining lysine and tryptophan to obtain polypeptide containing five or six amino acids; then amidation is carried out on the C terminal of the polypeptide, fatty acid chain modification is carried out on the N terminal and side chain amino groups, the ultra-short sequence antibacterial peptide rich in lysine and tryptophan is obtained, and the antibacterial peptide has broad-spectrum antibacterial activity for resisting gram-positive and gram-negative bacteria. An antibacterial peptide micelle self-assembly experiment shows that C12-2KW can be self-assembled into stable hydrogel in a 7.17 mu M PBS (Phosphate Buffer Solution), the hydrogel internally has a compact net-shaped structure, can completely cover the peritoneal injury surface and physically isolate the peritoneal injury surface from surrounding tissues, and has a good effect on treating wound infection caused by MRSA (Methicillin-Resistant Staphylococcus Aureus); meanwhile, the compound has the effect of resisting intestinal wall and abdominal wall adhesion after an operation, is low in toxicity, has a very good application prospect in the aspect of preparing clinical antibacterial drugs, and is expected to become a candidate drug of a novel antibiotic.
Owner:LANZHOU UNIV

Application of polypeptide compound in prevention and treatment of pathogenic microorganisms

PendingCN119798375ABiocideAntibacterial agentsEscherichia coliPyricularia grisea
The invention discloses application of polypeptide compounds in prevention and treatment of pathogenic microorganisms. The compound has a synergistic effect on agricultural fungi such as rhizoctonia solani, Sclerotinia sclerotiorum, Botrytis cinerea, Fusarium graminearum, Pyricaria oryzae, pyricularia oryzae, pyricularia oryzae, pyricularia oryzae, pyricularia oryzae, pyricularia oryzae, pyricularia oryzae, pyricularia oryzae, pyricularia oryzae, pyricularia oryzae, pyricularia oryzae, pyricularia oryzae and pyricularia oryzae. The method comprises the following steps: carrying out sterilization on plant bacteria such as Xanthomonas oryzae PXO99A, Xanthomonas axonophora dispsp.citrijx-6, Pseudomonas solanacearum (Smith) BNCC335855, Pseudomonas sp. The method is characterized by comprising the following steps of: killing Aspergillus flavus ACCC32601 (Aspergillus flavus), Penicillium expansum ACCC 30898 (Penicillium expansum. EXPANSum ACCC 30898), Monilinia coerulea ACCC 36263 (Aspergillus oryzae, Aspergillus niger, Aspergillus niger, Aspergillus niger, Aspergillus niger, Aspergillus niger, Aspergillus niger, Aspergillus niger and Aspergillus niger); the compound disclosed by the invention has a certain inhibition activity on various diseases caused by streptococcus agalactiae ATCC 27956, streptococcus dysgalactiae ATCC27957, Escherichia coli ATCC 25922 and Staphylococcus aureus, particularly, the compound Thiostreptin has a particularly remarkable inhibition effect on agricultural pathogenic bacteria, food-borne germs and cow mastitis germs, and is expected to be developed into a novel antibacterial drug, so that the compound disclosed by the invention can be used for preparing the antibacterial agent for preventing and treating various diseases caused by the streptococcus agalactiae ATCC 27956, the streptococcus dysgalactiae ATCC27957, the Escherichia coli ATCC 25922 and the Staphylococcus aureus.
Owner:LANZHOU UNIV

A broad-spectrum antibacterial peptide, its preparation method and application

The present invention discloses a broad-spectrum antibacterial peptide, and the amino acid sequence of the antibacterial peptide is GECEGNNRPVKKPQPRKKLPRFKKC-NH2. Based on melittin, the present invention designs antibacterial peptides by predicting based on a deep learning model, and obtains antibacterial peptides with broad-spectrum bacteriostasis, thermal stability and low hemolytic property, which have good inhibitory effects on skin pathogenic bacteria such as Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans and Propionibacterium acnes. Peptides predicted as AMP amino acid sequences by the deep learning model antibacterial peptide prediction tool amPEPpy are selected for screening, and by using a biosynthesis technique, they are expressed, extracted and purified in Escherichia coli, reducing the workload and screening period of screening, and increasing the probability of screening out broad-spectrum and thermally stable biosynthetic antibacterial peptides.
Owner:GUANGZHOU RIDGEPOLE BIOLOGICAL TECH CO LTD +1

Preparation method of viscose fiber based on wormwood essential oil / paraffin double-layer microcapsule

The invention relates to the technical field of preparation of viscose fibers, in particular to a preparation method of viscose fibers based on wormwood essential oil / paraffin double-layer microcapsules, which comprises the following preparation steps: S1, preparing the wormwood essential oil / paraffin double-layer microcapsules; s2, preparing a microcapsule spinning solution; s3, spinning and forming. According to the invention, the wormwood essential oil is coated in the double-layer microcapsule, so that the natural antibacterial property of the wormwood essential oil is fully exerted. Main active components (such as eucalyptol and flavonoid compounds) of the wormwood essential oil are continuously released through a microcapsule slow release mechanism, and growth of common pathogenic bacteria such as escherichia coli and staphylococcus aureus is remarkably inhibited. Meanwhile, due to the double-layer structure (the polyurethane inner shell and the polyurea outer shell) of the microcapsule, volatilization and oxidation of the wormwood essential oil in the spinning process are effectively avoided, and the long-acting antibacterial effect is ensured.
Owner:NANTONG SAIHUI TECH DEV

Antibacterial peptide as well as preparation method and application thereof

The invention discloses an antibacterial peptide as well as a preparation method and application thereof. The antibacterial peptide has an amino acid sequence as shown in any one of SEQ ID NO: 1-11. The antibacterial peptide prepared by the scheme provided by the invention has very strong bacteriostasis and sterilization capabilities on methicillin-resistant staphylococcus aureus and multidrug-resistant escherichia coli, has application potential of becoming an antibacterial agent, a preservative or a disinfectant, and is not easy to generate drug resistance.
Owner:WUHAN DEYUAN BIOTECHNOLOGY CO LTD

Purified cow milk antibacterial peptide produced by fermentation method and preparation method thereof

The invention discloses a preparation method and application of a cow milk antibacterial peptide with wide inhibitory activity on gram-positive bacteria and gram-negative bacteria by a fermentation method, the cow milk antibacterial peptide is prepared by taking milk protein as a raw material through a microbial fermentation method and a multi-stage membrane separation and purification process, the yield of the cow milk antibacterial peptide prepared by the method can reach 18-30%, and the yield of the cow milk antibacterial peptide prepared by the method can reach 18-30%. And the peptide content in the product is 60-85%. The cow milk antibacterial peptide prepared by the preparation method disclosed by the invention has inhibitory activity on gram-positive bacteria and gram-negative bacteria. The prepared cow milk antibacterial peptide can be used for preparing drugs and / or health care products, food and skin care products for preventing and / or reducing infectious diseases caused by escherichia coli, staphylococcus aureus, pseudomonas aeruginosa, porphyromonas gingivalis and streptococcus mutans, can also be used as a food preservative, an oral bacteriostatic agent, a preservative and the like, and has a good application prospect.
Owner:DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES

Supramolecular filamentous assemblies for protein purification

The present invention provide novel immunofiber compositions for protein or peptide purification and simple and cost-efficient methods and systems using these compositions. In some embodiments, the immunofibers comprise a customized Z-33 peptide derived from Staphylococcus aureus Protein A which is used to construct immuno-amphiphile molecules that assemble into immunofibers in aqueous solution with bioactive epitopes on the surface and have peptide or protein binding ability.
Owner:JOHNS HOPKINS UNIVERSITY +1

Antibacterial composition as well as preparation method and application thereof

The invention relates to the technical field of medicines, in particular to an antibacterial composition as well as a preparation method and application thereof. The invention provides an antibacterial composition. The antibacterial composition is prepared from the following components in parts by mass: 0.039 to 0.3125 part of SU3327 and 62.5 to 500 parts of citric acid. The combined use of the SU3327 and the citric acid can effectively kill and / or inhibit vibrio parahaemolyticus, escherichia coli, salmonella, acinetobacter baumannii, staphylococcus aureus, klebsiella pneumoniae and staphylococcus pseudointermediates, and the use amount of the SU3327 in the medicament for treating bacterial infection is greatly reduced; and the compound shows extremely high application value in the process of preparing medicines for treating bacterial infection.
Owner:CHINA AGRI UNIV +1

LL-37 derived antibacterial peptide and application thereof

The invention belongs to the technical field of antibacterial peptides, and particularly relates to an LL-37 derived antibacterial peptide and application thereof. According to the invention, 17-29aa of the LL-37 antibacterial peptide is used as a core fragment and is connected with an amino acid sequence shown as SEQ ID NO: 1 or SEQ ID NO: 2 through an amido bond, the antibacterial activity of the obtained antibacterial peptide is obviously higher than that of the LL-37 antibacterial peptide, and the antibacterial peptide shows an obvious bactericidal effect on clinical drug-resistant bacteria such as acinetobacter baumannii, pseudomonas aeruginosa, escherichia coli, staphylococcus aureus, klebsiella pneumoniae and the like; meanwhile, the cytotoxicity and hemolytic activity are weak, drug resistance is not prone to being generated, bacteria can be rapidly killed in vivo through multiple mechanisms, no obvious cytotoxicity exists, the bacterium load in tissue is remarkably reduced, and the lifetime of a bacterium-infected mouse is prolonged.
Owner:KUNMING INST OF ZOOLOGY CHINESE ACAD OF SCI

Self-cleaning antibacterial domestic ceramic and glaze and preparation process thereof

The invention discloses self-cleaning antibacterial domestic ceramic and glaze and a preparation process thereof. The preparation process comprises the following steps: step 1, early-stage research and innovative conception; 2, determining a core raw material and a formula; step 3, pretreating the raw materials; step 4, glaze preparation process; step 5, preparing a domestic ceramic green body; step 6, glazing and sintering process; the preparation method has the advantages that nano titanium dioxide added in the glaze can generate free radicals with strong oxidizing property under illumination, organic pollutants on the surface of ceramic can be decomposed, the self-cleaning function is achieved, meanwhile, nano silver and silver-loaded zirconium phosphate have good antibacterial performance, breeding of various bacteria can be effectively inhibited, the anti-bacterial performance is good, the service life of the glaze is prolonged, and the service life of the glaze is prolonged. The antibacterial rate on common bacteria such as escherichia coli and staphylococcus aureus can reach 95% or above, the raw materials are wide in source and meet the environment-friendly requirement, the conventional ball milling, forming, glazing and firing processes are adopted, industrial production is easy, the cost is low, and large-scale popularization of the product is facilitated.
Owner:CHAOZHOU GRAND HONOR CERAMIC CO LTD

Staphylococcus bacteriophage and uses thereof

A composition comprising at least two different strains of isolated bacteriophages, each capable of infecting a bacteria of the species Staphylococcus aureus, wherein at least one of said at least two different strains of isolated bacteriophages has a genomic nucleic acid sequence at least 90% identical to one of the nucleic acid sequence as set forth in SEQ ID NOs: 1-7. Uses thereof are also disclosed.
Owner:BIOMX LTD

A primer and probe set, kit, and application for detecting Staphylococcus aureus L based on real-time fluorescence MIRA technology.

This invention discloses a primer and probe set, a kit, and their applications for detecting Staphylococcus aureus L based on real-time fluorescence MIRA technology. The primer and probe set consists of single-stranded DNA sequences 1-3. Based on the aforementioned primer and probe set, this invention establishes and optimizes a real-time fluorescence MIRA detection method for Staphylococcus aureus L. Furthermore, the optimized real-time fluorescence MIRA method is innovatively combined with a simplified nucleic acid extraction method and a portable fluorescence detection device, significantly reducing extraction and time costs while enabling rapid on-site detection of the virus, making it particularly suitable for grassroots units and remote areas. In addition, the real-time fluorescence MIRA detection method for Staphylococcus aureus L established in this invention has advantages such as high specificity, high sensitivity, and simple operation. Moreover, the detection process does not require opening the lid, effectively avoiding aerosol contamination, providing an effective technical means for the differential diagnosis and rapid detection of Staphylococcus aureus L.
Owner:FRUIT TREE INST OF CHINESE ACAD OF AGRI SCI

Method and kit for treating skin infections

Method and kit for topical treatment of a skin infection, in particular of superficial skin infections, caused by Staphylococcus aureus. The method comprises the steps of applying a photosensitizer to at least a part of the skin affected by the infection, and subjecting said part of the skin to first photons with a majority energy between 2.8 eV and 3.5 eV at a first energy level; and second photons with a majority energy between 1.24 eV and 1.65 eV at a second energy level, the ratio between the first and the second energy levels being in the range from about 10:1 to 2:1. By the method efficient treatment of Staphylococcus aureus infections can be achieved without the administration of topical antibiotics.
Owner:KOITE HEALTH OY